Atlas Trials

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

Clinical trial NCT06795113 · RECRUITING

Trial details

NCT number
NCT06795113
Sponsor
Ruijin Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Lymphoma
Start date
2013-06-01
Primary completion
2029-12-31
Enrollment
4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.